Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03414671 · ClinicalTrials.gov registry record
The Effect of Standardizing the Definition of a Clinically Significant Cardiopulmonary Event on Length of Stay
A clinical trial of Apnea of Prematurity, sponsored by Pediatrix.
- Completed
- Registry status
- 160
- Enrollment target
- 1
- Study location
NCT03414671: Completed study of Apnea of Prematurity, sponsored by Pediatrix.
NCT03414671 is a study of Apnea of Prematurity that has completed, run by Pediatrix. The registered enrollment target is 160 participants, below the 382-participant average among 6 other Apnea of Prematurity trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03414671, a study of Apnea of Prematurity, has completed, sponsored by Pediatrix.
- COMPLETED
- Registry status
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
A health care initiative will be implemented December 4, 2017 in the Newborn Intensive Care (NICU) setting in an attempt to reduce the length of stay (LOS) for premature infants after standardizing the definition and approach to a clinically significant cardiopulmonary event (CSCPE). We would like to compare LOS in infants born \< 30 weeks gestation before and after standardization to see if LOS is reduced.
Primary Outcome
reduce the length of stay (LOS) for premature infants after standardizing the definition and approach to a clinically significant cardiopulmonary event
Conditions Studied
Study Locations (1)
Washington
- Swedish Medical Center First Hill - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2021-09-21 |
What the finished NCT03414671 record still lists
NCT03414671 is an observational study that tracks outcomes without assigning an intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 382-participant average among 6 other Apnea of Prematurity trials with a reported enrollment target (58% lower).
The record links to 1 condition, with Apnea of Prematurity appearing as the primary indexed condition, and to 0 interventions.
NCT03414671 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT03414671 about?
NCT03414671 is a clinical study titled "The Effect of Standardizing the Definition of a Clinically Significant Cardiopulmonary Event on Length of Stay". A health care initiative will be implemented December 4, 2017 in the Newborn Intensive Care (NICU) setting in an attempt to reduce the length of stay (LOS) for premature infants after standardizing the definition and approach to a clinically significant cardiopulmonary event (CSCPE). We would like t...
What is the current status of trial NCT03414671?
This trial is currently completed. The enrollment target is 160 participants. The study started on 2018-06-01. Estimated completion is 2021-09-21.
What conditions does trial NCT03414671 study?
This clinical trial studies the following conditions: Apnea of Prematurity.
Who is sponsoring clinical trial NCT03414671?
This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03414671 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Apnea of Prematurity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants
RECRUITING · NA
-
"Prapela® SVS Incubator Pad for Apnea of Prematurity
RECRUITING · NA
-
Caffeine Use in the Management of Preterm Infants
ACTIVE NOT RECRUITING · Phase 2
-
A Comparison of Non-invasive Ventilation Methods Used to Prevent Endotracheal Intubation Due to Apnea in Very Low Birth Weight Infants
COMPLETED · NA
-
Caffeine for Apnea of Prematurity (CAP)
COMPLETED · Phase 3
-
Arterial Oxygen Saturation on Ventilatory Stability in Extremely Premature Infants
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI